Close Menu

USPTO

Title: Compositions and Methods for Inhibiting Expression of a Target Gene
Patent Number: 8,546,143
Filed: Sept. 29, 2010
Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received an ex parte re-examination certificate from the US Patent and Trademark Office for certain claims related to the company's non-coding DNA patent.

Title: Compositions and Methods for siRNA Inhibition of Angiogenesis
Patent Number: 8,541,384
Filed: June 8, 2006
Lead Inventor: Michael Tolentino, University of Pennsylvania

Title: Lentiviral Transduced Dendritic Cells for RNAi
Patent Number: 8,530,153
Filed: March 10, 2011
Inventor: Sam Kam Pun Kung, University of Manitoba

Title: Method and Substances for Isolating miRNAs
Patent Number: 8,524,448
Filed: Aug. 29, 2012
Lead Inventor: Elliott Dawson, Bioventures

Title: Method of Diagnosing Poor-survival-prognosis Colon Cancer Using miR-16b
Patent Number: 8,518,647
Filed: Nov. 14, 2011
Lead Inventor: Carlo Croce, Ohio State University

Title: Methods for Diagnosing Stomach Cancer Using microRNAs
Patent Number: 8,512,951
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

Title: Methods for Diagnosing Pancreatic Cancer Using microRNAs
Patent Number: 8,507,202
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

Title: Vector
Patent Number: 8,501,466
Filed: Dec. 17, 2009
Lead Inventor: Venugopal Nair, Pirbright Institute

Title: Triggered RNAi
Patent Number: 8,497,364
Filed: Feb. 27, 2009
Lead Inventor: Niles Pierce, California Institute of Technology

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.